Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Regulatory approval of Basilea's Toctino recommended under European decentralized procedure

July 31, 2008

MediGene's Oracea receives marketing authorization in Europe

July 30, 2008

Xoma commences phase IIa XOMA-629 study in patients with impetigo

July 28, 2008

Galderma receives Japanese marketing and manufacturing approval for Differin in acne

July 18, 2008

Allergan acquires acne treatment Aczone from QLT for USD 150 million

July 16, 2008

OrthoLogic initiates dosing in AZX-100 phase I dermal/hypertrophic scarring trial

July 11, 2008

Welichem's phase I WBI-1001 trial meets endpoints in psoriasis

July 10, 2008

Tripep submits new application to Medical Products Agency for phase II study of ChronSeal

July 8, 2008

Recent Wyeth and Curis patent imparts new therapeutic agents for alopecia

July 7, 2008

VioQuest submits 510(k) application to FDA for Xyfid for skin disorders

July 2, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...